Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

1900 Søernes Privathospital ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   0.0% 15.5% 9.7% 5.5% 6.8% 7.1% 16.2% 15.9%   Credit score (0-100)   0 12 24 41 34 34 11 12   Credit rating   N/A BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 -0.0 -0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 -1,602 16,737 44,919 39,303 33,801 0.0 0.0   EBITDA   0.0 -1,851 -977 3,091 1,198 -1,037 0.0 0.0   EBIT   0.0 -1,851 -2,658 666 -1,739 -3,650 0.0 0.0   Pre-tax profit (PTP)   0.0 -1,919.1 -2,986.1 143.2 -2,551.1 -4,669.0 0.0 0.0   Net earnings   0.0 -1,497.2 -2,339.3 120.6 -1,977.8 -3,669.1 0.0 0.0   Pre-tax profit without non-rec. items   0.0 -1,919 -2,986 143 -2,551 -4,669 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 9,195 14,364 13,575 16,758 15,231 0.0 0.0   Shareholders equity total   0.0 -1,337 -3,676 444 347 -229 -537 -537   Interest-bearing liabilities   0.0 12,285 16,480 11,341 13,145 11,775 537 537   Balance sheet total (assets)   0.0 12,832 25,453 25,277 26,137 25,806 0.0 0.0   Net Debt   0.0 10,026 16,480 10,423 13,132 11,766 537 537     See the entire balance sheet 1000.0 Volume  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 -1,602 16,737 44,919 39,303 33,801 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 168.4% -12.5% -14.0% -100.0% 0.0%   Employees   0 0 18 38 44 36 0 0   Employee growth %   0.0% 0.0% 0.0% 111.1% 15.8% -18.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 12,832 25,453 25,277 26,137 25,806 0 0   Balance sheet change%   0.0% 0.0% 98.4% -0.7% 3.4% -1.3% -100.0% 0.0%   Added value   0.0 -1,851.3 -976.7 3,091.1 685.5 -1,037.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 9,195 3,487 -3,213 245 -4,140 -15,231 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 -1.0 -2.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 115.6% -15.9% 1.5% -4.4% -10.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% -13.1% -12.3% 2.4% -6.8% -14.0% 0.0% 0.0%   ROI %   0.0% -15.1% -17.6% 4.5% -13.8% -28.9% 0.0% 0.0%   ROE %   0.0% -11.7% -12.2% 0.9% -500.2% -28.1% 0.0% 0.0%   1000.0 Solidity  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   0.0% -9.4% -12.6% 1.8% 1.3% -0.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -541.6% -1,687.3% 337.2% 1,096.5% -1,134.5% 0.0% 0.0%   Gearing %   0.0% -918.8% -448.2% 2,553.5% 3,792.6% -5,136.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 1.1% 2.3% 3.8% 6.6% 8.2% 0.0% 0.0%   1000.0 Liquidity  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.0 1.0 0.6 0.7 0.4 0.4 0.0 0.0   Current Ratio   0.0 1.1 0.6 0.8 0.5 0.5 0.0 0.0   Cash and cash equivalent   0.0 2,259.5 0.0 917.5 13.7 9.1 0.0 0.0   1000.0 Capital use efficiency  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 185.7 -6,053.6 -2,177.7 -8,454.3 -10,490.0 -268.3 -268.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 N/A 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -54 81 16 -29 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -54 81 27 -29 0 0   EBIT / employee   0 0 -148 18 -40 -101 0 0   Net earnings / employee   0 0 -130 3 -45 -102 0 0